SCHEMBL823707

SCHEMBL823707

CCOc1nc(N)nc2ccc(-c3cccc(NS(=O)(=O)c4ccc(C)cc4)c3)nc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.51
LMNA P02545 7/20 0.51
POLB P06746 1/20 0.51
TP53 P04637 3/20 0.46
THRB P10828 2/20 0.46
ALDH1A1 P00352 7/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
USP2 O75604 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
PIK3CB P42338 1/20 0.45
DHFR P00374 1/20 0.44
HSP90AA1 P07900 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 3/20 0.42
HPGD P15428 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823663 0.89 DHFR (0.54) MAPTLMNAPOLBTP53THRB
SCHEMBL823645 0.87 DHFR (0.48) MAPTLMNAPOLBTP53THRB
SCHEMBL823634 0.84 KDM1A (0.46) MAPTLMNAPOLBTP53THRB
SCHEMBL823710 0.84 NR3C2 (0.48) MAPTLMNAPOLBTP53ALDH1A1
SCHEMBL823669 0.83 SYK (0.43) MAPTLMNAPOLBTP53THRB
SCHEMBL823636 0.83 DHFR (0.45) MAPTLMNAPOLBTP53THRB
SCHEMBL823659 0.82 DHFR (0.44) MAPTLMNAPOLBTP53THRB
SCHEMBL823668 0.79 MAPT (0.42) MAPTLMNAPOLBTP53ALDH1A1
SCHEMBL4513221 0.78 RXFP1 (0.43) MAPTLMNAPOLBTP53ALDH1A1
SCHEMBL823769 0.77 DHFR (0.40) MAPTLMNAPOLBTP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US claimed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
WO-2008077649-A1 PYRIDO(3,2-D)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTONS GILEAD SCIENCES, INC. (US) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS PNPO, DPYD, PLPBP MAPT 2803/4885LMNA 3578/4885POLB 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.